Entrada Therapeutics, Inc. was added to the Russell 2000 Value-Defensive Index and the Russell 2000 Defensive Index on June 30, 2025. These inclusions are part of the annual reconstitution of the widely recognized Russell indexes.
The addition to these indexes can enhance Entrada's visibility within the investment community. It may also lead to increased demand for the company's stock from passive funds and exchange-traded funds (ETFs) that track these benchmarks.
This development reflects Entrada's growing market presence and could contribute to improved liquidity for its shares. The Russell 2000 is a key benchmark for small-cap U.S. equities, and inclusion signifies a certain level of market capitalization and trading activity.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.